Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$966M |
| 2 |
Microsoft
MSFT
|
+$734M |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$643M |
| 4 |
IBM
IBM
|
+$529M |
| 5 |
Philip Morris
PM
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
ExxonMobil
XOM
|
+$971M |
| 3 |
Applied Materials
AMAT
|
+$728M |
| 4 |
Honeywell
HON
|
+$684M |
| 5 |
TSMC
TSM
|
+$562M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.2% |
| 2 | Financials | 11.32% |
| 3 | Healthcare | 9.56% |
| 4 | Industrials | 9.21% |
| 5 | Consumer Discretionary | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
V2X
VVX
$2.6B
| $8.72M | ﹤0.01% |
116,931
+17,834
| +18% | +$1.33M |
|
2102
Seaboard Corp
SEB
$4.18B
| $8.69M | ﹤0.01% |
1,948
+51
| +3% | +$267K |
|
2103
Klaviyo
KVYO
$5.26B
| $8.66M | ﹤0.01% |
573,727
-934,410
| -62% | -$15.5M |
|
2104
Relay Therapeutics
RLAY
$4.35B
| $8.66M | ﹤0.01% |
462,756
+79,836
| +21% | +$1.16M |
|
2105
Arcutis Biotherapeutics
ARQT
$3.29B
| $8.66M | ﹤0.01% |
330,094
+24,562
| +8% | +$572K |
|
2106
Edgewise Therapeutics
EWTX
$4.8B
| $8.63M | ﹤0.01% |
212,347
+19,913
| +10% | +$686K |
|
2107
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.08B
| $8.6M | ﹤0.01% |
134,457
-114,243
| -46% | -$6.96M |
|
2108
REX American Resources
REX
$1.47B
| $8.6M | ﹤0.01% |
190,443
-1,592
| -0.8% | -$73.7K |
|
2109
1st Source
SRCE
$2.13B
| $8.57M | ﹤0.01% |
105,103
+101
| +0.1% | +$7.54K |
|
2110
Entravision Communication
EVC
$832M
| $8.55M | ﹤0.01% |
655,702
+31,657
| +5% | +$224K |
|
2111
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.92B
| $8.54M | ﹤0.01% |
153,219
+2,744
| +2% | +$140K |
|
|
STUB
2112
StubHub Holdings
STUB
$3.03B
| $8.53M | ﹤0.01% |
662,503
+639,625
| +2,796% | +$5.64M |
|
2113
MillerKnoll
MLKN
$1.62B
| $8.52M | ﹤0.01% |
416,387
+8,823
| +2% | +$141K |
|
|
SKYT
2114
DELISTED
SkyWater Technology
SKYT
| $8.51M | ﹤0.01% |
244,415
+140,807
| +136% | +$4.82M |
|
2115
DoubleVerify
DV
$2.04B
| $8.51M | ﹤0.01% |
784,928
+69,086
| +10% | +$711K |
|
2116
Collegium Pharmaceutical
COLL
$916M
| $8.51M | ﹤0.01% |
234,960
+9,255
| +4% | +$316K |
|
2117
FMC
FMC
$1.27B
| $8.5M | ﹤0.01% |
738,930
+60,135
| +9% | +$839K |
|
2118
Willis Lease Finance
WLFC
$1.2B
| $8.5M | ﹤0.01% |
111,387
+8,919
| +9% | +$583K |
|
2119
Methanex
MEOH
$4.34B
| $8.49M | ﹤0.01% |
183,909
-378,220
| -67% | -$22.3M |
|
2120
Vera Therapeutics
VERA
$2.28B
| $8.48M | ﹤0.01% |
197,694
+18,340
| +10% | +$683K |
|
2121
Intapp
INTA
$3.09B
| $8.48M | ﹤0.01% |
336,400
-46,200
| -12% | -$1.05M |
|
2122
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $8.48M | ﹤0.01% |
366,146
-67,214
| -16% | -$1.55M |
|
2123
TriCo Bancshares
TCBK
$1.84B
| $8.38M | ﹤0.01% |
155,587
+2,460
| +2% | +$125K |
|
2124
Intuitive Machines
LUNR
$3.05B
| $8.35M | ﹤0.01% |
390,314
+41,145
| +12% | +$1.16M |
|
2125
Schwab Emerging Markets Equity ETF
SCHE
$12.8B
| $8.34M | ﹤0.01% |
230,053
+34,423
| +18% | +$1.23M |
|
Similar funds
Bank of New York Mellon's Q2 2026 Portfolio in Review
As of Q2 2026, Bank of New York Mellon held 4,477 positions worth $609B, up 12% from $544B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q2 2026 filing shows 283 new, 2,266 increased, 1,637 reduced and 188 closed positions. Its largest new stake was Honeywell Aerospace: 2,914,841 shares worth $644M. The largest sale was Apple, an estimated $1.07B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q2 2026 buy was Honeywell Aerospace: 2,914,841 shares worth $644M.
- Bank of New York Mellon added most to Marvell Technology in Q2 2026, an estimated $966M increase.
- Bank of New York Mellon's biggest Q2 2026 reduction was Apple, cutting an estimated $1.07B.
- Bank of New York Mellon fully exited Coterra Energy in Q2 2026, selling an estimated $298M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $609B portfolio in Q2 2026.
- Bank of New York Mellon opened 283 new positions and closed 188 in Q2 2026.
- Bank of New York Mellon's portfolio value rose 12% quarter-over-quarter to $609B.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.